About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Ectopic Cushing Syndrome Secondary to Metastatic Small Cell Carcinoma of Unknown Primary: A Multidisciplinary Approach
Colin Pierce1, Niyoti Reddy2, Joseph Rencic1, Umit Tapan3, Ivania M. Rizo2
1Department of Medicine, Section of Internal Medicine, Boston University Medical Center; 2Division of Endocrinology, Diabetes, Nutrition, and Weight Management, Section of Internal Medicine, Boston University Medical Center; 3Division of Oncology, Section of Internal Medicine, Boston University Medical Center, Boston, MA 02118.
Corresponding Author:
Dr Ivania M. Rizo
Email: Ivania.rizo@bmc.org
Received: 24-AUG-2022 Accepted: 30-OCT-2023 Published Online: 05-JAN-2024
DOI: http://dx.doi.org/10.17659/01.2024.0001
Abstract
Background: Small cell lung cancer (SCLC) is a neuroendocrine tumor with the possibility to produce various peptides or hormones that can lead to paraneoplastic syndromes, such as ectopic ACTH secretion (EAS). The diagnosis of EAS is challenging and requires a multidisciplinary approach. Case Report: We report a case of a 64-year-old man who presented severe hypokalemia, metabolic alkalosis, worsening hyperglycemia and hypertension, found to have EAS secondary to metastatic small cell carcinoma of unknown primary. Conclusion: We review therapeutic options, including chemo-immunotherapy as part of the treatment regimen, for EAS.
Keywords : Adrenocorticotropic Hormone, Cushing Syndrome, Neuroendocrine Tumors, Small Cell Carcinoma.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports

abortion pill online

Secure abortion pill tablets. There he could simply order pill for abortion online generic.There we could simply order generic site.
Last updated on Apr 05, 2024